Concepts (89)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Infectious Disease Medicine | 2 | 2020 | 49 | 1.090 |
Why?
|
| Physician-Patient Relations | 4 | 2022 | 3249 | 0.880 |
Why?
|
| Podiatry | 1 | 2022 | 28 | 0.830 |
Why?
|
| Communicable Diseases | 2 | 2022 | 875 | 0.810 |
Why?
|
| Faculty, Medical | 3 | 2020 | 1203 | 0.780 |
Why?
|
| Empathy | 2 | 2017 | 473 | 0.770 |
Why?
|
| Bacteriuria | 1 | 2022 | 102 | 0.750 |
Why?
|
| Guilt | 1 | 2021 | 96 | 0.720 |
Why?
|
| Ritonavir | 2 | 2012 | 329 | 0.660 |
Why?
|
| Diabetic Foot | 1 | 2022 | 380 | 0.620 |
Why?
|
| Osteomyelitis | 1 | 2022 | 407 | 0.620 |
Why?
|
| Career Mobility | 1 | 2020 | 259 | 0.610 |
Why?
|
| Naloxone | 1 | 2018 | 370 | 0.500 |
Why?
|
| Disease Transmission, Infectious | 1 | 2021 | 559 | 0.500 |
Why?
|
| Truth Disclosure | 1 | 2017 | 434 | 0.420 |
Why?
|
| Triamcinolone Acetonide | 1 | 2012 | 100 | 0.400 |
Why?
|
| Interdisciplinary Studies | 1 | 2012 | 86 | 0.390 |
Why?
|
| Attitude of Health Personnel | 2 | 2018 | 3889 | 0.380 |
Why?
|
| Medicine | 1 | 2020 | 942 | 0.380 |
Why?
|
| HIV Protease Inhibitors | 2 | 2012 | 432 | 0.370 |
Why?
|
| Cushing Syndrome | 1 | 2012 | 241 | 0.370 |
Why?
|
| Dibenzothiazepines | 1 | 2009 | 102 | 0.330 |
Why?
|
| Iatrogenic Disease | 1 | 2012 | 539 | 0.330 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2011 | 258 | 0.320 |
Why?
|
| Internal Medicine | 1 | 2016 | 1051 | 0.310 |
Why?
|
| Internship and Residency | 2 | 2018 | 5880 | 0.280 |
Why?
|
| Family | 1 | 2017 | 3194 | 0.260 |
Why?
|
| Education, Medical, Graduate | 1 | 2018 | 2373 | 0.260 |
Why?
|
| Curriculum | 1 | 2018 | 3743 | 0.240 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 5840 | 0.230 |
Why?
|
| Oligopeptides | 1 | 2009 | 1187 | 0.230 |
Why?
|
| Glucocorticoids | 1 | 2012 | 2161 | 0.210 |
Why?
|
| Students, Medical | 1 | 2016 | 1936 | 0.210 |
Why?
|
| Clinical Competence | 1 | 2018 | 4792 | 0.200 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 4320 | 0.180 |
Why?
|
| Cardiology | 1 | 2012 | 1656 | 0.180 |
Why?
|
| Education, Medical | 1 | 2012 | 1725 | 0.170 |
Why?
|
| Bicycling | 1 | 2021 | 177 | 0.170 |
Why?
|
| Colonic Neoplasms | 1 | 2011 | 2538 | 0.160 |
Why?
|
| Achievement | 1 | 2020 | 288 | 0.160 |
Why?
|
| Academic Medical Centers | 2 | 2022 | 2759 | 0.160 |
Why?
|
| Pyridines | 1 | 2009 | 2875 | 0.150 |
Why?
|
| Physicians | 1 | 2015 | 4591 | 0.140 |
Why?
|
| Drug Interactions | 2 | 2012 | 1416 | 0.140 |
Why?
|
| Administration, Intranasal | 1 | 2018 | 477 | 0.130 |
Why?
|
| Antipsychotic Agents | 1 | 2009 | 3067 | 0.130 |
Why?
|
| Sex Factors | 2 | 2020 | 10552 | 0.130 |
Why?
|
| Anti-Infective Agents | 1 | 2023 | 983 | 0.130 |
Why?
|
| Accidents, Traffic | 1 | 2021 | 816 | 0.120 |
Why?
|
| Focus Groups | 1 | 2020 | 1413 | 0.120 |
Why?
|
| Anti-Bacterial Agents | 2 | 2022 | 7407 | 0.110 |
Why?
|
| Narcotic Antagonists | 1 | 2018 | 585 | 0.110 |
Why?
|
| Schools, Medical | 1 | 2020 | 879 | 0.110 |
Why?
|
| Medicare Payment Advisory Commission | 1 | 2012 | 14 | 0.100 |
Why?
|
| Humans | 16 | 2023 | 761504 | 0.100 |
Why?
|
| Splenic Artery | 1 | 2011 | 57 | 0.090 |
Why?
|
| Specialization | 1 | 2016 | 778 | 0.090 |
Why?
|
| Injections, Epidural | 1 | 2012 | 201 | 0.090 |
Why?
|
| Parent-Child Relations | 1 | 2015 | 761 | 0.090 |
Why?
|
| Career Choice | 1 | 2016 | 756 | 0.080 |
Why?
|
| Models, Educational | 1 | 2012 | 373 | 0.080 |
Why?
|
| Sex Characteristics | 1 | 2020 | 2639 | 0.080 |
Why?
|
| Back Pain | 1 | 2012 | 545 | 0.080 |
Why?
|
| Aneurysm | 1 | 2011 | 337 | 0.080 |
Why?
|
| Parvoviridae Infections | 1 | 2007 | 36 | 0.070 |
Why?
|
| Parvovirus B19, Human | 1 | 2007 | 40 | 0.070 |
Why?
|
| Female | 8 | 2022 | 392644 | 0.070 |
Why?
|
| HIV Infections | 1 | 2012 | 17351 | 0.070 |
Why?
|
| Male | 6 | 2022 | 360804 | 0.060 |
Why?
|
| Interprofessional Relations | 1 | 2012 | 990 | 0.060 |
Why?
|
| United States | 3 | 2020 | 72334 | 0.060 |
Why?
|
| Retrospective Studies | 2 | 2022 | 80636 | 0.050 |
Why?
|
| Attitude to Health | 1 | 2011 | 2025 | 0.050 |
Why?
|
| Analgesics, Opioid | 1 | 2018 | 3808 | 0.050 |
Why?
|
| Adult | 5 | 2022 | 221177 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2009 | 6310 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2012 | 8631 | 0.040 |
Why?
|
| Death | 1 | 2023 | 676 | 0.040 |
Why?
|
| Goals | 1 | 2023 | 711 | 0.040 |
Why?
|
| Disease Outbreaks | 1 | 2007 | 1749 | 0.040 |
Why?
|
| Multiple Myeloma | 1 | 2015 | 5146 | 0.040 |
Why?
|
| Quality of Life | 2 | 2023 | 13367 | 0.030 |
Why?
|
| Prognosis | 1 | 2015 | 29625 | 0.030 |
Why?
|
| Motivation | 1 | 2023 | 2006 | 0.030 |
Why?
|
| Pregnancy | 1 | 2011 | 29874 | 0.020 |
Why?
|
| Middle Aged | 2 | 2012 | 220895 | 0.020 |
Why?
|
| Community-Acquired Infections | 1 | 2007 | 469 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 2007 | 3156 | 0.010 |
Why?
|
| Recurrence | 1 | 2007 | 8465 | 0.010 |
Why?
|
Concepts
(89)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(23)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_